SCHEMBL4102305

SCHEMBL4102305

O=Cc1ccc2cccc(Cl)c2c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.50
▸ CYP2A6 P11509 5/20 0.48
▸ CYP1A2 P05177 2/20 0.48
▸ KIF11 P52732 2/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ VCAM1 P19320 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.40
▸ ALDH1A3 P47895 3/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ PTGER4 P35408 1/20 0.38
▸ ALDH3A1 P30838 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5406345 0.85 ALDH1A1 (0.50) ALDH1A1CYP2A6CYP1A2KIF11MEN1
SCHEMBL215676 0.81 CYP2A6 (0.48) ALDH1A1CYP2A6CYP1A2MEN1KMT2A
SCHEMBL9883875 0.78 KIF11 (0.42) ALDH1A1CYP2A6KIF11MEN1KMT2A
SCHEMBL5617799 0.78 ALDH1A1 (0.56) ALDH1A1CYP2A6CYP1A2KIF11MEN1
SCHEMBL5381553 0.77 PTGER4 (0.50) ALDH1A1CYP2A6KIF11MEN1KMT2A
SCHEMBL476028 0.77 CTDSP1 (0.53) ALDH1A1CYP2A6CYP1A2KIF11TDP1
SCHEMBL29953436 0.77 PTGER4 (0.50) ALDH1A1CYP2A6KIF11MEN1KMT2A
SCHEMBL3257311 0.77 CYP2A6 (0.57) ALDH1A1CYP2A6CYP1A2KIF11KMT2A
SCHEMBL29951748 0.77 ALDH1A1 (0.50) ALDH1A1CYP2A6CYP1A2KIF11MEN1
SCHEMBL29957704 0.77 CYP2A6 (0.57) ALDH1A1CYP2A6CYP1A2KIF11KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103539737-B A kind of azepine phenanthro- fluorene kind derivative, preparation method and electroluminescent fluorescent luminescent device TCL集团股份有限公司 2017-03-08 — — CN disclosed
US-20090221645-A1 Dihydroimidazothiazole Derivatives PROSIDION LIMITED (GB) 2009-09-03 — — US disclosed
US-20090221645-A1 Dihydroimidazothiazole Derivatives PROSIDION LIMITED (GB) 2009-09-03 — — US disclosed
US-20090221645-A1 Dihydroimidazothiazole Derivatives PROSIDION LIMITED (GB) 2009-09-03 — — US disclosed
CN-101155817-A Dihydroimidazothiazole derivatives PROSIDION LTD (GB) 2008-04-02 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221645-A1 Dihydroimidazothiazole Derivatives TPH1, HTR3B, HTR1A ALDH1A1 195/4885CYP2A6 447/4885CYP1A2 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback